Showing results (351-360 of 1,919) with videos related to
Sort By:
Pageof 192
Cancer Biomarkers : Section a of Disease Markers|January 28, 2017
MicroRNA in breast cancer: The association with BRCA1/2Nina Petrovic, Radoslav Davidovic, Vladan Bajic, et al.Cancer Biomarkers : Section a of Disease Markers|January 28, 2017
MicroRNA-21 contributes to the discrimination of chemoresistance in metastatic gastric cancerMing Qi, Dongmei Liu, Shuhong ZhangCancer Biomarkers : Section a of Disease Markers|December 1, 2007
Detection of the JAK2V617F mutation by asymmetric PCR and melt curve analysisBobbie Collett Sutton, Richard A Allen, Zhizhuang Joe Zhao, et al.Cancer Biomarkers : Section a of Disease Markers|December 1, 2007
Association between VEGF expression in tumour-associated macrophages and elevated serum VEGF levels in primary colorectal cancer patientsFrancisco J Gonzalez, Luis Vicioso, Martina Alvarez, et al.Cancer Biomarkers : Section a of Disease Markers|November 2, 2016
Placental type alkaline phosphatase tissue expression in ovarian serous carcinomaMaria Orsaria, Ambrogio P Londero, Stefania Marzinotto, et al.Cancer Biomarkers : Section a of Disease Markers|November 2, 2016
Diagnostic and prognostic roles of serum vitronectin in hepatitis B-related hepatocellular carcinomaXiao-Ping Yang, Li-Xing Zhou, Qi-Jun Yang, et al.Cancer Biomarkers : Section a of Disease Markers|March 6, 2014
Heterogeneous nuclear ribonucleoprotein U-like 1 and Poly (ADP-ribose) polymerase 1 are downregulated in renal cell carcinoma and connected with the prognosisTing Xu, Qing Zou, Jing Wu, et al.Cancer Biomarkers : Section a of Disease Markers|March 6, 2014
N-acetyltransferase 2 phenotype and risk of esophageal cancer: a meta analysisRuo-Lan Ma, Li Min, Duo Chen, et al.Cancer Biomarkers : Section a of Disease Markers|March 6, 2014
microRNA-210 as a prognostic factor in patients with breast cancer: meta-analysisYanyan Li, Xuelei Ma, Jingyi Zhao, et al.Cancer Biomarkers : Section a of Disease Markers|March 6, 2014
Meta-analysis of phospholipase C epsilon 1 polymorphism and cancer riskYu Zhang, Ruixia Wang, Longbiao Zhu, et al.Pageof 192